Skip to main content

Closed

ALT: Altimmune, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-269216.7%

ROIC-29.9%

Financially safe

Stretched

Debt / equity0.13×

Interest coverage-35.9×

Current ratio29.56×

Altimmune, Inc.

ALTNASDAQ Global Market·USD·Closed

Altimmune, Inc.

ALTNASDAQ·USD·Closed

$2.84

−4.70%

$2.84

−$0.14 (4.70%)

52W Range

7thpctl

Volume

0.96×avg

Mkt Cap

250.65MUSD

P/E

-3.1TTM

Div Yield

–ann

52W Range

7thpctl

Volume

0.96×avg

Market Cap

250.65MUSD

P/E Ratio

-3.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings